HHC
SLXP

Hutchin Hill Capital’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Hutchin Hill Capital’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,380
Closed -$1.1M – 937
2015
Q1 		$1.1M Buy
+6,380
New +$937K 0.03% 424
2013
Q4 		– Sell
-29,100
Closed -$1.95M – 726
2013
Q3 		$1.95M Buy
29,100
+12,300
+73% +$848K 0.18% 103
2013
Q2 		$1.11M Buy
+16,800
New +$961K 0.11% 109

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Hutchin Hill Capital's SLXP Position: Q2 2015 in Review

Hutchin Hill Capital sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 6,380 shares — an estimated $1.1M sold.

Hutchin Hill Capital first reported a position in SLXP in Q2 2013 and held it in 3 quarters. The position peaked at $1.95M in Q3 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Hutchin Hill Capital reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Hutchin Hill Capital sold 6,380 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.1M.
  • Hutchin Hill Capital first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 3 quarters.
  • Hutchin Hill Capital's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.95M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Hutchin Hill Capital's 13F filing for Q2 2015, filed 14 Aug 2015.